Emily J. Cook

Practice Areas

Partner Emily Jane Cook advises healthcare providers on complex regulatory and reimbursement matters, enabling them to evaluate and mitigate the compliance risks of new business initiatives and existing service lines. As a widely-recognized national authority on the 340B drug pricing program, Emily counsels healthcare providers and other stakeholders on issues related to implementation, compliance and advocacy. With her extensive regulatory experience, she effectively and efficiently provides guidance to clients on a wide range of key concerns, such as fee-for-service Medicare and Medicaid reimbursement, billing and coding, licensure, survey/certification and accreditation, and compliance with Medicare and state fraud and abuse requirements. She also advises clients facing government audits, whistleblowers actions, and self-disclosures, working to preserve their government program participation and reduce or eliminate government program refunds and administrative penalties.

Emily works with providers, including hospitals, health systems and academic medical centers, to develop and implement innovative care models, including collaborative care models across facilities and between different types of clinical professionals. Her counsel enables her clients to maximize care quality and efficiency while maintaining regulatory compliance.

View more: https://www.mwe.com/people/cook-emily-j/

Professional Memberships

American Health Lawyers Association, Planning Committee for Institute on Medicare and Medicaid Payment Issues

California Lawyers Association, Health Law Committee, chair, 2019-2020

Work Highlights

Obtained favorable outcomes for clients in whistleblower actions, government investigations, regulatory appeals and self-disclosures to federal and state regulatory agencies, preserving government program participation and reducing or eliminating government program refunds and administrative penalties.

Counseled large national health systems and academic medical centers through the development and implementation of innovative care models, including collaborative care models across facilities and between different types of clinical professionals, intended to maximize care quality and efficiency while maintaining regulatory compliance.

Successfully appealed adverse findings in government audits of 340B programs for multiple hospital clients and negotiated corrective action plans, enabling the hospitals to continue leveraging program participation to their patients and communities.